Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
Public ClinicalTrials.gov record NCT02688517. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Targeted Genomic Analysis of Human Cancers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This research trial studies the use of targeted genomic analysis of blood and tissue samples from patients with cancer. Genomic sequencing is a laboratory method that is used to determine the entire genetic makeup of a specific organism or cell type. Genomic sequencing can be used to find changes in areas of the genome that may be important in the development of cancer. It may also help doctors improve ways to diagnose and treat patients with rare cancers with poor prognosis or lack of effective therapy.
Study identification
- NCT ID
- NCT02688517
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,100 participants
Conditions and interventions
Conditions
Interventions
Other
Eligibility (public fields only)
- Age range
- 1 Year and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2013
- Primary completion
- Apr 30, 2030
- Completion
- Apr 30, 2030
- Last update posted
- Apr 16, 2026
2013 – 2030
United States locations
- U.S. sites
- 11
- U.S. states
- 2
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ocean Medical Center | Brick | New Jersey | 08724 | Completed |
| Bayshore Community Hospital | Holmdel | New Jersey | 07733 | Completed |
| RWJBarnabas Health - Jersey City Medical Center, Jersey City | Jersey City | New Jersey | 07302 | Recruiting |
| Southern Ocean County Medical Center | Manahawkin | New Jersey | 08050 | Completed |
| Morristown Medical Center | Morristown | New Jersey | 07960 | Completed |
| Jersey Shore Medical Center | Neptune City | New Jersey | 07753 | Completed |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | Recruiting |
| Riverview Medical Center/Booker Cancer Center | Red Bank | New Jersey | 07701 | Completed |
| Riverview Medical Center | Red Bank | New Jersey | 07701 | Active, not recruiting |
| Overlook Hospital | Summit | New Jersey | 07902 | Completed |
| University of Wisconsin Hospital and Clinics | Madison | Wisconsin | 53792 | Withdrawn |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02688517, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2026 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02688517 live on ClinicalTrials.gov.